Hi, what are you looking for?
L.A. County sues Roblox, alleges platform makes it easy for adults to target children
CFTC chief sides with prediction markets over state regulators in a high-stakes court case
Warner Bros. Discovery reopens talks with Paramount
Justice Department’s antitrust chief says she’s leaving, effective immediately
Cardi B’s cameo in Bad Bunny’s Super Bowl halftime show leads to dispute on prediction markets
Bold Ventures Provides Update on Burchell Drilling Progress and Announces PDAC Participation at Booth #2610
55 North Mining Announces Closing of Flow-Through Financing
Crypto Market Update: Bitcoin Price Retreats Again After Mid-week Rise
Tech Weekly: Stocks See Minor Reprieve Before Ending Week in the Red
Top 5 Canadian Mining Stocks This Week: Adex Mining Shines with 171 Percent Gain
Chart Mania – 23 ATR Move in QQQ – Metals Lead 2025 – XLV Oversold – XLU Breakout – ITB Moment of Truth
Momentum Leaders Are Rotating — Here’s How to Find Them
S&P 500 Breaking Out Again: What This Means for Your Portfolio
Is META Breaking Out or Breaking Down?
A Wild Ride For the History Books: 2025 Mid-Year Recap
Dems’ potential 2028 hopefuls come out against US strikes on Iran
From hostage crisis to assassination plots: Iran’s near half-century war on Americans
Sustained war with Iran could drain US missile stockpiles, test escalation control
Khamenei’s death opens uncertain chapter for Iran’s entrenched theocracy
Putin: Killing of Khamenei a ‘cynical violation’ of morality
Adrian Day, president of Adrian Day Asset Management, shares his thoughts on gold’s latest price activity, saying the metal is still ‘nowhere near a top.’
In his view, its long-term drivers remain in place, and two new ones have now emerged.
Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.
Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need,...
Is the market’s next surge already underway? Find out with Tom Bowley’s breakdown of where the money is flowing now and how you can get...
The chart of Meta Platforms, Inc. (META) has completed a roundtrip from the February high around $740 to the April low at $480 and...
Markets don’t usually hit record highs, risk falling into bearish territory, and spring back to new highs within six months. But that’s what happened...